Financhill
Buy
68

COR Quote, Financials, Valuation and Earnings

Last price:
$291.24
Seasonality move :
2.19%
Day range:
$290.03 - $295.25
52-week range:
$218.65 - $309.35
Dividend yield:
0.74%
P/E ratio:
33.79x
P/S ratio:
0.19x
P/B ratio:
55.73x
Volume:
3.9M
Avg. volume:
1.8M
1-year change:
32.06%
Market cap:
$56.4B
Revenue:
$294B
EPS (TTM):
$8.62

Earnings Data

Next earnings date for COR
Jul 31
2025
Most recent earnings per share
$3.68
Missed by $0.42
(May 7/2025)
Consensus Estimate
$4.10
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

COR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q2 $80.3B -- -- $3.78 --
05/07/2025 Q1 $75.8B $75.5B $3.68 $4.10 -$0.42
02/05/2025 Q4 $78.2B $81.5B $2.50 $3.52 -$1.02
11/06/2024 Q3 $77.7B $79.1B $0.02 $3.23 -$3.21
07/31/2024 Q2 $73.3B $74.2B $2.42 $3.22 -$0.80
05/01/2024 Q1 $70.8B $68.4B $2.09 $3.69 -$1.60
01/31/2024 Q4 $69.2B $72.3B $2.98 $2.89 $0.09
11/02/2023 Q3 $66.1B $68.9B $1.72 $2.81 -$1.09
08/02/2023 Q2 $63.9B $66.9B $2.35 $2.83 -$0.48
03/31/2023 Q1 $60.4B $63.5B $2.13 $3.30 -$1.17
12/31/2022 Q4 -- $62.8B $2.33 -- --
09/30/2022 Q3 -- $61.2B $1.40 -- --
06/30/2022 Q2 -- $60.1B $1.92 -- --
03/31/2022 Q1 -- $57.7B $2.59 -- --
02/04/2022 Q4 -- $59.6B $2.13 -- --
10/28/2021 Q3 -- $58.9B $2.08 -- --
07/29/2021 Q2 -- $53.4B $1.40 -- --
04/29/2021 Q1 -- $49.2B $2.10 -- --
02/04/2021 Q4 -- $52.5B $1.81 -- --
10/29/2020 Q3 -- $49.2B -$23.74 -- --
07/30/2020 Q2 -- $45.4B $1.41 -- --
04/30/2020 Q1 -- $47.4B $4.64 -- --
02/06/2020 Q4 -- $47.9B $0.90 -- --
10/31/2019 Q3 -- $45.6B $0.63 -- --
07/24/2019 Q2 -- $45.2B $1.43 -- --
04/24/2019 Q1 -- $43.3B $0.13 -- --
02/07/2019 Q4 -- $45.4B $1.84 -- --
10/25/2018 Q3 -- $43.3B $1.09 -- --
07/26/2018 Q2 -- $43.1B $1.25 -- --
04/26/2018 Q1 -- $41B $1.29 -- --
02/08/2018 Q4 -- $40.5B $3.90 -- --
10/26/2017 Q3 -- $39.1B -$1.35 -- --
07/27/2017 Q2 -- $38.7B $0.23 -- --
04/27/2017 Q1 -- $37.1B $1.86 -- --
02/09/2017 Q4 -- $38.2B $1.11 -- --
10/27/2016 Q3 -- $37.6B $0.62 -- --
07/28/2016 Q2 -- $36.9B $1.55 -- --
04/28/2016 Q1 -- $35.7B $2.68 -- --
02/11/2016 Q4 -- $36.7B $1.45 -- --
10/22/2015 Q3 -- $35.5B $1.56 -- --
07/23/2015 Q2 -- $34.2B $0.89 -- --

Cencora Earnings Questions

  • How Much did Cencora Generate in Revenue Last Quarter?

    Cencora reported $75.5B worth of top line sales in its most recent quarter.

  • Did Cencora Beat Earnings Last Quarter?

    Cencora announced earnings per share of $3.68 which represents a miss of analyst forecast a $4.10 per share.

  • Is Cencora Profitable?

    Cencora reported $3.1B that represents $15.68 per share over the last quarter.

  • What is the Analyst Consensus for Cencora EPS Next Year?

    Cencora's earnings are forecast to grow from $7.53 per share to $15.79 per share next year representing an increase of 109.75%.

  • When is Cencora's Earnings Date?

    Cencora's next earnings date is July 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock